Hasvold, L P
Bodegård, J
Thuresson, M
Stålhammar, J
Hammar, N
Sundström, J
Russell, D
Kjeldsen, S E
Article History
Received: 1 February 2014
Revised: 25 April 2014
Accepted: 1 May 2014
First Online: 26 June 2014
Competing interests
: LPH is enrolled at the PhD School of the University of Oslo, Faculty of Medicine. LPH, NH and JB are employed by AstraZeneca. AstraZeneca sells candesartan in many markets. Candesartan has lost patent protection. MT is employed by an independent statistical consultant company, Statisticon, for which AZ is a client. J Stålhammar has received honoraria for lecturing/consulting and other research support from AZ. J Sundström has received honoraria for advisory board participation from AZ. DR has received honoraria for lecturing/consulting and other research support from AZ, Boehringer Ingelheim, Pfizer and Bayer. SEK has received honoraria for lecturing/consulting and other research support from AZ, Bayer, Medtronic, MSD, Pronova, Serodus and Takeda.